Final answer:
Mixed-Mechanism Glaucoma (MMG) is a condition characterized by fluid accumulation in the eye lens. It can be treated with acetazolamide, an enzyme inhibitor. Glaucoma is commonly detected by measuring intraocular pressure.
Step-by-step explanation:
Mixed-Mechanism Glaucoma (MMG) is a condition characterized by the accumulation of fluid in the lens of the eye, resulting in enlargement. Glaucoma can be treated with a medication called 'acetazolamide,' which inhibits the enzyme carbonic anhydrase. This medication competitively prevents water formation and reduces the release of excess water through urine.
This type of glaucoma is an example of non-competitive enzyme inhibition. Non-competitive inhibition is shown by regulatory enzymes, also known as allosteric enzymes, which can modify the activity of target enzymes through non-competitive binding sites.
Glaucoma is more common in people over 40 years of age and is usually detected by measuring intraocular pressure. High intraocular pressure can be detected and sometimes controlled effectively using non-contact methods that measure the force needed to indent the eye.